{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T02:19:25Z","timestamp":1715998765889},"reference-count":24,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1573,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1479-828x.2011.01314.x","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T11:01:49Z","timestamp":1305198109000},"page":"372-376","source":"Crossref","is-referenced-by-count":13,"title":["A case study of trastuzumab treatment for metastatic breast cancer in pregnancy: fetal risks and management of cerebral metastases"],"prefix":"10.1111","volume":"51","author":[{"given":"Christine L.","family":"MANDRAWA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine","family":"STEWART","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin C.","family":"FABINYI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan P.","family":"WALKER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,5,12]]},"reference":[{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ctrv.2005.04.008","article-title":"Central nervous system metastases in breast cancer patients administered trastuzumab","volume":"31","author":"Duchnowska","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer; correlation of relapse and survival with amplication of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1200\/JCO.2005.01.014","article-title":"Phase II study of efficacy, safety, and pharmacokinetics of trastuzumab monotherapy administered on a 3-weekly schedule","volume":"23","author":"Baselga","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1470-2045(06)71014-2","article-title":"Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy","volume":"8","author":"Bader","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ajog.2009.02.017","article-title":"Herceptin (trastuzumab) therapy in a twin pregnancy associated with oligohydramnios","volume":"201","author":"Beale","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3816\/CBC.2005.n.040","article-title":"Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy","volume":"6","author":"Fanale","year":"2005","journal-title":"Clin Breast Cancer"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1200\/JCO.2008.16.0309","article-title":"Treatment of breast cancer with trastuzumab during pregnancy","volume":"26","author":"Pant","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.AOG.0000267133.65430.44","article-title":"Trastuzumab use for metastatic breast cancer in pregnancy","volume":"110","author":"Sekar","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/01.AOG.0000141570.31218.2b","article-title":"Herceptin (Trastuzumab) therapy during pregnancy: association with reversible anhydramnios","volume":"105","author":"Watson","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/annonc\/mdm542","article-title":"Trastuzumab in pregnancy associated with poor fetal outcome","volume":"19","author":"Witzel","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/BF00852567","article-title":"Expression of the epidermal growth factor in fetal kidney","volume":"7","author":"Goodyer","year":"1993","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.reprotox.2008.02.002","article-title":"Trastuzumb exposure during pregnancy","volume":"25","author":"Weber-Schoendorfer","year":"2008","journal-title":"Reprod Toxicol"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrclinonc.2009.48","article-title":"Breast cancer and pregnancy: how safe is trastuzumab?","volume":"6","author":"Azim","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1186\/1757-1626-2-9329","article-title":"Safety of trastuzumab (Herceptin) during pregnancy: two case reports","volume":"2","author":"Goodyer","year":"2009","journal-title":"Cases J"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB16|cit16","first-page":"31","article-title":"Trastuzumab treatment for breast cancer during pregnancy","volume":"54","author":"Shrim","year":"2008","journal-title":"Can Fam Physician"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.reprotox.2007.11.004","article-title":"Ectopic pregnancy in a breast cancer patient receiving trastuzumab","volume":"25","author":"Berveiller","year":"2008","journal-title":"Reprod Toxicol"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1634\/theoncologist.12-7-766","article-title":"Central nervous system metastases in HER-2-positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors","volume":"12","author":"Gori","year":"2007","journal-title":"Oncologist"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1200\/JCO.2000.18.11.2349","article-title":"Trastuzumab in CSF","volume":"18","author":"Pestalozzi","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1200\/JCO.2008.19.8481","article-title":"Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases","volume":"27","author":"Leyland-Jones","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/AOG.0b013e318180a505","article-title":"Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation","volume":"112","author":"Chen","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2214\/AJR.06.1616","article-title":"ACR guidance document for safe MR practices","volume":"188","author":"Kanal","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.2007.117002","article-title":"Neurosurgery and pregnancy","volume":"79","author":"Ng","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1479-828X.2011.01314.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1200\/JCO.2005.04.6607","article-title":"Effect of adjuvant trastuzumab on pregnancy","volume":"24","author":"Waterson","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1479-828X.2011.01314.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1479-828X.2011.01314.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T05:01:55Z","timestamp":1612674115000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1479-828X.2011.01314.x"}},"subtitle":["Trastuzumab in pregnancy, brain mets and fetal risks"],"short-title":[],"issued":{"date-parts":[[2011,5,12]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1479-828x.2011.01314.x","relation":{},"ISSN":["0004-8666"],"issn-type":[{"value":"0004-8666","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5,12]]}}}